Global Remifentanil Hydrochloride for Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Remifentanil Hydrochloride for Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Remifentanil Hydrochloride for Injection has analgesic effect. The main active ingredient is remifentanil, which belongs to opioid agonists. It exerts obvious analgesic effect by stimulating opioid receptors.
Remifentanil Hydrochloride for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2024. Global Remifentanil Hydrochloride for Injection market is projected to reach US$ 752.2 million in 2034, increasing from US$ 414 million in 2024, with the CAGR of 8.9% during the period of 2023 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Remifentanil Hydrochloride for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034.
Globally, Remifentanil Hydrochloride for Injection key manufacturers include Jiangsu Nhua Pharmaceutical, Yichang Renfu Pharmaceutical, Sinopharm Group, Aspen, Fresenius Kab and Sandoz, etc. Jiangsu Nhua Pharmaceutical, Yichang Renfu Pharmaceutical, Sinopharm Group are top 3 players and held % sales share in total in 2024.
Remifentanil Hydrochloride for Injection can be divided into 1mg/vial, 2mg/vial and 5mg/via,, etc. 1mg/vial is the mainstream product in the market, accounting for % sales share globally in 2024.
Remifentanil Hydrochloride for Injection is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Remifentanil Hydrochloride for Injection industry development. In 2024, global % sales of Remifentanil Hydrochloride for Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remifentanil Hydrochloride for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Jiangsu Nhua Pharmaceutical
Yichang Renfu Pharmaceutical
Sinopharm Group
Aspen
Fresenius Kab
Sandoz
Segment by Type
1mg/vial
2mg/vial
5mg/via
Hospital
Clinic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remifentanil Hydrochloride for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Remifentanil Hydrochloride for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Remifentanil Hydrochloride for Injection industry.
Chapter 3Historical (2018-2024) and forecast (2024-2034) volume and revenue analysis of Remifentanil Hydrochloride for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Remifentanil Hydrochloride for Injection introduction, etc. Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Remifentanil Hydrochloride for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Remifentanil Hydrochloride for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2024. Global Remifentanil Hydrochloride for Injection market is projected to reach US$ 752.2 million in 2034, increasing from US$ 414 million in 2024, with the CAGR of 8.9% during the period of 2023 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Remifentanil Hydrochloride for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034.
Globally, Remifentanil Hydrochloride for Injection key manufacturers include Jiangsu Nhua Pharmaceutical, Yichang Renfu Pharmaceutical, Sinopharm Group, Aspen, Fresenius Kab and Sandoz, etc. Jiangsu Nhua Pharmaceutical, Yichang Renfu Pharmaceutical, Sinopharm Group are top 3 players and held % sales share in total in 2024.
Remifentanil Hydrochloride for Injection can be divided into 1mg/vial, 2mg/vial and 5mg/via,, etc. 1mg/vial is the mainstream product in the market, accounting for % sales share globally in 2024.
Remifentanil Hydrochloride for Injection is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Remifentanil Hydrochloride for Injection industry development. In 2024, global % sales of Remifentanil Hydrochloride for Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remifentanil Hydrochloride for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Jiangsu Nhua Pharmaceutical
Yichang Renfu Pharmaceutical
Sinopharm Group
Aspen
Fresenius Kab
Sandoz
Segment by Type
1mg/vial
2mg/vial
5mg/via
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remifentanil Hydrochloride for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Remifentanil Hydrochloride for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Remifentanil Hydrochloride for Injection industry.
Chapter 3Historical (2018-2024) and forecast (2024-2034) volume and revenue analysis of Remifentanil Hydrochloride for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Remifentanil Hydrochloride for Injection introduction, etc. Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Remifentanil Hydrochloride for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
